Photo:

Contrast agents

Many procedures in diagnostic imaging would be impossible without contrast agents: they open up insights into vascular structures, show stenoses, inflammations, aneurysms and more. However, reports about side effects – especially with gadolinium-based contrast media – cause uncertainty among many patients.

Photo

News • Transport of minuscule gold particles

Nanoparticles could detect kidney disease better than blood tests

Before administering certain drugs, doctors check a patient’s kidney function by testing their blood urea nitrogen and creatinine levels. New research shows that gold nanoparticles might give more…

Photo

News • Macrocyclic hybrid probe

New dual PET/MRI contrast agent to enhance kidney diagnostics

A new type of contrast agent for use in both MRI and PET imaging has the potential to significantly enhance diagnosis and subsequent treatment, particularly for kidney diseases and tumors.

Photo

News • CT-Derived Functional Imaging

CTFI: Enabling CT lung diagnosis without contrast

Diagnosing lung conditions such as pulmonary embolism is more challengenging when a patient cannot tolerate contrast agents. Now, a new software solution is addressing the issue.

Photo

News • Potential alternative to gadolinium

Diamond dust: the bright new MRI contrast agent?

Diamond dust could be used in MR imaging, a surprising find shows. The nanometer-sized particles could serve as an alternative to the controversial contrast agent gadolinium.

Photo

News • Cardiovascular disease detection

Routine chest CT with AI to assess CVD risk

AI-enhanced CT scans can accurately evaluate cardiovascular risk without contrast media, a new study shows. The technique uses coronary calcium and heart chamber size as markers for disease detection.

Photo

News • Biparametric scan

Prostate cancer screening: two-part MRI is enough, study shows

A three-part ‘multiparametric’ MRI of the prostate is standard of care in the UK for patients suspected of having prostate cancer. Now, a study shows two-part scans are sufficient for diagnosis.

Photo

Article • Medical imaging

Contrast media utilisation: trends and breakthroughs

Striking the balance between diagnostic efficacy and patient safety remains critical when utilising iodinated contrast media to deliver the best imaging outcomes. While playing a crucial role in diagnosis and treatment of disease, CT expert Efthimios Agadakos believes the medical profession has a duty to do its utmost to minimize patient risk from contrast media.

Photo

Article • Impact of ICM packaging and delivery systems

Contrast media bottles: benefits of switching to multi-dose

Iodinated contrast media (ICM) enhance CT imaging, but its single-dose packaging is increasingly proving at odds with modern, more sustainable imaging practices. New award-winning research by a radiology resident and faculty members at Vanderbilt University Medical Center in Nashville, Tennessee, proposes a promising alternative: A switch from using single-dose injectable contrast media kits to…

Photo

Article • Plenary discussion at ECR 2023

Sustainable radiology: why it takes more than “greener” imaging systems

It’s clear that radiology is lacking in the “green” department: healthcare still causes a large share of global greenhouse gas (GHG) emissions, not least due to diagnostic imaging. Dr Sarah Sheard from Imperial College Healthcare, UK, invited her ECR audience to take a closer look at radiology’s climate footprint – and revealed ways to make the field more sustainable.

Photo

Sponsored • Optimization for CT

An update for contrast agent injection

The Accutron CT-D Vision is the next generation of the leading contrast agent injector for computed tomography from Medtron AG. Focusing on the needs of the user, the latest development stage of the Accutron CT-D improves the usability of the CT double-piston contrast agent injector and optimizes its integration into the radiological environment.

Photo

Article • Imaging resource management

Managing the CT contrast media shortage with clinical decision support tools

On March 31st, 2022, a city-wide lockdown to curtail the spread of the Covid-19 virus in Shanghai, China, shuttered the GE Healthcare manufacturing facility that produces 80% of the global supply of iodinated contrast media agents iohexol (Omnipaque) and lodixanol (Visipaque). Although the plant was able to operate at 50% capacity by mid-May, the shutdown resulted in a substantial contrast media…

Photo

News • Vital imaging

Study: contrast MRI after a heart attack could increase survival

A new study from the University of Surrey and University College London has revealed that treatment for heart attacks could be improved thanks to a novel method of evaluating heart function using contrast-based MRI scans. According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 per cent) of all deaths in the UK, which equates to more than 160,000…

Photo

News • Safe sonography

Medical societies support safety and benefits of ultrasound contrast agents

The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke,…

112 show more articles
Subscribe to Newsletter